Wright Medical Group, Inc. Introduces CORETRAK Articulating External Fixator for Foot Surgery

ARLINGTON, Tenn.--(Business Wire)--
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device
company, announced the launch of its patent pending CORETRAK Articulating
External Fixator. The CORETRAK articulating fixator design is well-suited for
challenging fixation cases of the foot, such as those involving diabetic
patients.

The goal of Wright`s CORETRAK articulating fixator design is to simplify the
procedure for the surgeon, the patient, and hospital staff. The device also
addresses a growing need for minimally invasive solutions that respect the
body`s natural ability to heal, which is particularly important for the growing
population of diabetics who are already at a high risk for surgical
complications.

Robert D. Santrock, M.D. of Midlands Orthopedics in Columbia, South Carolina,
specializes in the care and treatment of the diabetic foot and its associated
complications. Dr. Santrock expressed, "The new articulating CORETRAK fixator
will take external fixation to a new level with its low profile,
patient-friendly design and adaptability to multiple conditions in the foot."
His associate William C. James, III, M.D. noted, "External fixation is
particularly useful for the diabetic foot due to its ability to stabilize bones
while avoiding areas with open wounds and/or infection. I find it a useful tool
for reconstructing the foot in a high risk patient."

Bradley M. Lamm, D.P.M., Head of Foot and Ankle Surgery, International Center
for Limb Lengthening of the Rubin Institute for Advanced Orthopedics at Sinai
Hospital in Baltimore, Maryland further commented, "I am looking forward to this
new technology for the treatment of arthritis in the big toe joint. The CORETRAK
articulating fixator has specific design features to address pain and stiffness
in the toe joint and may save a patient from a joint replacement or fusion."

Wright`s CORETRAK Articulating Fixator is provided in a sterile packaged
procedure kit to save surgical facilities time and expense of cleaning and
sterilizing. The kits may also be useful for military and emergency operations
where time is critical. The new CORETRAK fixator will be made available
immediately in the U.S. through Wright`s specialized foot and ankle sales force,
and in select countries outside the U.S. through its direct and
distributor-based sales representatives.

The CORETRAK fixator is the latest addition to Wright`s market-leading suite of
products for foot and ankle surgeons. These include the CHARLOTTE family of
reconstructive implants, DARCO locked plating systems, ORTHOLOC variable angle
plates, the BIOARCH subtalar implant, CANCELLO-PURE and BIOFOAM osteotomy wedge
systems, ENDO-FUSE implants, DART-FIRE small screw systems, GRAFTJACKET
regenerative tissue matrix, and the INBONE total ankle.

Wright Medical Group, Inc. is a global orthopaedic medical device company
specializing in the design, manufacture and marketing of reconstructive joint
devices and biologics. The Company has been in business for more than 50 years
and markets its products in over 60 countries worldwide. For more information
about Wright Medical, visit the company`s website at www.wmt.com.

This press release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended.All statements made in this press
release, other than statements of historical fact, are forward-looking
statements.Forward-looking statements reflect management's current knowledge,
assumptions, beliefs, estimates, and expectations and express management's
current views of future performance, results, and trends and may be identified
by their use of terms such as "anticipate," "believe," "could," "estimate,"
"expect," "intend," "may," "plan," "predict," "project," "will," and other
similar terms. The Company wishes to caution readers that actual results might
differ materially from those described in the forward-looking statements.
Forward-looking statements are subject to a number of risks and uncertainties,
including the factors discussed in the Company`s filings with the Securities and
Exchange Commission (including the Company`s annual report on Form 10-K for the
year ended December 31, 2008, under the heading, "Risk Factors"), which could
cause the Company`s actual results to materially differ from those described in
the forward-looking statements. Although the Company believes that the
forward-looking statements are accurate, there can be no assurance that any
forward-looking statement will prove to be accurate. A forward-looking statement
should not be regarded as a representation by the Company that the results
described therein will be achieved.The Company wishes to caution readers not to
place undue reliance on any forward-looking statement.The forward-looking
statements are made as of the date of this press release. The Company assumes no
obligation to update any forward-looking statement after this date.

Wright Medical Group, Inc.
John K. Bakewell, 901-867-4527

Copyright Business Wire 2009